Press "Enter" to skip to content

New patent for Janssen Pharms drug INVEGA SUSTENNA

2
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug INVEGA SUSTENNA

Annual Drug Patent Expirations for INVEGA+SUSTENNA
Annual Drug Patent Expirations for INVEGA+SUSTENNA

Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.

INVEGA SUSTENNA drug price trends.

Drug patent litigation for INVEGA SUSTENNA.

This drug has twenty-four patent family members in seventeen countries.

The generic ingredient in INVEGA SUSTENNA is paliperidone palmitate. One supplier is listed for this compound. Additional details are available on the paliperidone palmitate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug INVEGA SUSTENNA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!